NA-731 is under clinical development by Biomed Industries and currently in Phase I for Traumatic Brain Injury.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback